Anti-inflammatory Molecule Can Pass Brain Barrier, May Treat MS

Anti-inflammatory Molecule Can Pass Brain Barrier, May Treat MS

299020

Anti-inflammatory Molecule Can Pass Brain Barrier, May Treat MS

A potential anti-inflammatory treatment, xB3-IL-1RA was able to reach the central nervous system of a rodent model of multiple sclerosis (MS), and with repeat doses delay disease onset and ease clinical symptoms, according to the investigational therapy’s developer Bioasis Technologies. These findings support the utility of Bioasis’ xB3 peptide platform in helping to deliver medicines into the brain and spinal cord (the central nervous system or CNS) through the blood-brain barrier — a highly selective membrane…

You must be logged in to read/download the full post.